Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs auto...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Regenerative Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320420300699 |
id |
doaj-f91055e59c2340d4bb90eaaee247b29c |
---|---|
record_format |
Article |
spelling |
doaj-f91055e59c2340d4bb90eaaee247b29c2020-12-23T05:00:31ZengElsevierRegenerative Therapy2352-32042020-12-0115305311Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on miceKoichiro Tsujimaru0Masakatsu Takanashi1Katsuko Sudo2Akio Ishikawa3Shoichiro Mineo4Shinobu Ueda5Katsuyoshi Kumagai6Masahiko Kuroda7Department of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanPreclinical Research Center, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanPreclinical Research Center, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, JapanDepartment of Molecular Pathology, Tokyo Medical University, Japan; Corresponding author. Department of Molecular Pathology, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. Fax: +81-3-3352-6335.Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs autoimmune disease. Interestingly, IL-1 receptor antagonist deficient (IL-1ra−/−) mice induce inflammation in joints like RA. In RA therapy, although AMSC improves the inflammation activity, it is little known to play roles of extracellular microvesicles (EV) for improvement of RA. To clarify the MSC-derived EVs are involved amelioration mechanisms for RA by themselves, we examined the functional effects of development for RA by AMSC-EVs. Methods: We isolated AMSCs derived mice adipose tissue and purified EVs from the culture supernatant of AMSCs. To examine whether EVs can improve RA, we administrated EVs or AMSCs to IL-1ra knockout mice as RA model mice. We analyzed EVs-included factor by western blot methods and RA improvement effect by ELISA. Results: In this study, we showed that the swellings of joints on mice in wild type AMSC and that in AMSC-EVs decreased than that in IL-1ra−/− mice-AMSC-EVs and in none-treated. We detected IL-1ra expression in AMSC-EVs in wild type mice but not that in IL-1ra−/− mice. Proinflammatory cytokine expression changes in mice showed in AMSCs and AMSC-EVs, but no apparent differences cytokine expressions were detected in IL-1ra−/− mice. Conclusions: In this study, we concluded that MSCs might improve RA by the transferring of factors such as IL-1ra, which are included their MSC derived- EVs.http://www.sciencedirect.com/science/article/pii/S2352320420300699Adipose-derived mesenchymal stem cellsExtracellular vesicleIL-1 receptor antagonistArthritis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Koichiro Tsujimaru Masakatsu Takanashi Katsuko Sudo Akio Ishikawa Shoichiro Mineo Shinobu Ueda Katsuyoshi Kumagai Masahiko Kuroda |
spellingShingle |
Koichiro Tsujimaru Masakatsu Takanashi Katsuko Sudo Akio Ishikawa Shoichiro Mineo Shinobu Ueda Katsuyoshi Kumagai Masahiko Kuroda Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice Regenerative Therapy Adipose-derived mesenchymal stem cells Extracellular vesicle IL-1 receptor antagonist Arthritis |
author_facet |
Koichiro Tsujimaru Masakatsu Takanashi Katsuko Sudo Akio Ishikawa Shoichiro Mineo Shinobu Ueda Katsuyoshi Kumagai Masahiko Kuroda |
author_sort |
Koichiro Tsujimaru |
title |
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
title_short |
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
title_full |
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
title_fullStr |
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
title_full_unstemmed |
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
title_sort |
extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice |
publisher |
Elsevier |
series |
Regenerative Therapy |
issn |
2352-3204 |
publishDate |
2020-12-01 |
description |
Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs autoimmune disease. Interestingly, IL-1 receptor antagonist deficient (IL-1ra−/−) mice induce inflammation in joints like RA. In RA therapy, although AMSC improves the inflammation activity, it is little known to play roles of extracellular microvesicles (EV) for improvement of RA. To clarify the MSC-derived EVs are involved amelioration mechanisms for RA by themselves, we examined the functional effects of development for RA by AMSC-EVs. Methods: We isolated AMSCs derived mice adipose tissue and purified EVs from the culture supernatant of AMSCs. To examine whether EVs can improve RA, we administrated EVs or AMSCs to IL-1ra knockout mice as RA model mice. We analyzed EVs-included factor by western blot methods and RA improvement effect by ELISA. Results: In this study, we showed that the swellings of joints on mice in wild type AMSC and that in AMSC-EVs decreased than that in IL-1ra−/− mice-AMSC-EVs and in none-treated. We detected IL-1ra expression in AMSC-EVs in wild type mice but not that in IL-1ra−/− mice. Proinflammatory cytokine expression changes in mice showed in AMSCs and AMSC-EVs, but no apparent differences cytokine expressions were detected in IL-1ra−/− mice. Conclusions: In this study, we concluded that MSCs might improve RA by the transferring of factors such as IL-1ra, which are included their MSC derived- EVs. |
topic |
Adipose-derived mesenchymal stem cells Extracellular vesicle IL-1 receptor antagonist Arthritis |
url |
http://www.sciencedirect.com/science/article/pii/S2352320420300699 |
work_keys_str_mv |
AT koichirotsujimaru extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT masakatsutakanashi extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT katsukosudo extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT akioishikawa extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT shoichiromineo extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT shinobuueda extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT katsuyoshikumagai extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice AT masahikokuroda extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice |
_version_ |
1724373598352703488 |